Become an expert in R — Interactive courses, Cheat Sheets, certificates and more!
Get Started for Free

cisapride

Cisapride in Non-Ulcer Dispepsia


Description

Meta-analysis on cisapride in non-ulcer dispepsia.

This meta-analysis is used as a data example in Hartung and Knapp (2001).

Format

A data frame with the following columns:

study study label
event.cisa number of events in cisapride group
n.cisa number of observations in cisapride group
event.plac number of events in placebo group
n.plac number of observations in placebo group

Source

Hartung J & Knapp G (2001): A refined method for the meta-analysis of controlled clinical trials with binary outcome. Statistics in Medicine, 20, 3875–89

See Also

Examples

data(cisapride)

m.or <- metabin(event.cisa, n.cisa, event.plac, n.plac,
                data = cisapride, sm = "OR", method = "Inverse",
                studlab = study, addincr = TRUE)

s1 <- summary(update(m.or, sm = "RR"))
s2 <- summary(update(m.or, sm = "RR", hakn = TRUE))
#
s3 <- summary(m.or)
s4 <- summary(update(m.or, hakn = TRUE))

vars <- c("TE", "lower", "upper")

# Results for log risk ratio - see Table VII in Hartung and Knapp (2001) 
#
res.rr <- rbind(data.frame(s1$fixed)[vars],
                data.frame(s1$random)[vars],
                data.frame(s2$random)[vars])
#
row.names(res.rr) <- c("FE", "RE", "RE (HaKn)")
names(res.rr) <- c("Log risk ratio", "CI lower", "CI upper")
#
res.rr


# Results for log odds ratio (Table VII in Hartung and Knapp 2001) 
#
res.or <- rbind(data.frame(s3$fixed)[vars],
                data.frame(s3$random)[vars],
                data.frame(s4$random)[vars])
#
row.names(res.or) <- c("FE", "RE", "RE (HaKn)")
names(res.or) <- c("Log odds ratio", "CI lower", "CI upper")
#
res.or

meta

General Package for Meta-Analysis

v4.18-0
GPL (>= 2)
Authors
Guido Schwarzer [cre, aut] (<https://orcid.org/0000-0001-6214-9087>)
Initial release
2021-03-05

We don't support your browser anymore

Please choose more modern alternatives, such as Google Chrome or Mozilla Firefox.